Dendritic cell viability is decreased after phagocytosis of apoptotic tumor cells induced by staurosporine or vaccinia virus infection

Haematologica

Volumn 88, Issue 12, 2003, Pages 1396-1404

  Di Nicola, Massimo ^a   Napoli, Sara ^a   Anichini, Andrea ^a   Mortarini, Roberta ^a   Romagnoli, Luca ^a   Magni, Michele ^a   Matteucci, Paola ^a   Baldassarri, Paola ^a   Bersani, Ilaria ^a   Carlo Stella, Carmelo ^b   Gianni, Alessandro M ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Anticancer vaccine; Apoptosis; Dendritic cells; Immunotherapy; Non Hodgkin's lymphoma

Indexed keywords

APOPTOSIS INDUCING FACTOR; CANCER VACCINE; STAUROSPORINE; TUMOR ANTIGEN;

APOPTOSIS; ARTICLE; B LYMPHOBLAST; B LYMPHOCYTE; CANCER IMMUNOTHERAPY; CELL KILLING; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; MONOCYTE; NONHODGKIN LYMPHOMA; PHAGOCYTOSIS; T LYMPHOCYTE ACTIVATION; TUMOR CELL; ULTRAVIOLET C RADIATION; VACCINATION; VACCINIA VIRUS; VIRUS PARTICLE;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; APOPTOSIS; B-LYMPHOCYTES; CANCER VACCINES; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; DENDRITIC CELLS; HUMANS; INTERFERON TYPE II; LEUKEMIA, LYMPHOCYTIC, CHRONIC; LYMPHOMA, FOLLICULAR; MONOCYTES; PHAGOCYTOSIS; STAUROSPORINE; T-LYMPHOCYTES; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS; VACCINATION; VACCINIA VIRUS;

EID: 0347363718     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998;392:245-52
2. Hart DNJ. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood 1997;9:3245-87.
3. Troy AJ, Hart DNJ. Dendritic cells and cancer: progress toward a new cellular therapy. J Hematother 1997;6:523-33.
4. Merad M, Angevin E, Wolfers J, Flament C, Lorenzi I, Triebel F, et al. Generation of monocyte-derived dendritic cells from patients with renal cell cancer: modulation of their functional properties after therapy with biological response modifiers (IFN-α plus IL-2 and IL-12). J Immunother 2000;23:369-78.
5. Hinkel A, Tso CL, Gitlitz BJ, Neagos N, Schmid I, Paik SH, et al. Immunomodulatory dendritic cells generated from nonfractionated bulk peripheral blood mononuclear cell cultures induce growth of cytotoxic T cells against renal cell carcinoma. J Immunother 2000;23:83-93.
6. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, et al. Vaccination of melanoma patients with peptide or tumor lysate pulsed dendritic cells. Nat Med 1998;4:328-32.
7. + T cells for efficient tumor cell lysis. Can Res 2000;60:4446-52.
8. Boczkowski D, Nair SK, Snyder D, Gilboa E. Dendritic cells pulsed with RNA are potent antigen presenting cells in vitro and in vivo. J Exp Med 1996;184:465-72.
9. Di Nicola M, Siena S, Bregni M, Longoni P, Magni M, Milanesi M, et al. Gene transfer into human dendritic antigen presenting cells by vaccinia virus and adenovirus vectors. Cancer Gene Ther 1998;5:350-6
10. Gong J, Chen L, Chen D, Kashiwaba M, Manome Y, Tanaka T, et al. Induction of antigen-specific antitumor immunity with adenovirus transduced dendritic cells. Gene Ther 1998;4:1023-8.
11. Gilboa E, Nair SK, Lyerly HK. Immunotherapy of cancer with dendritic-cell-based vaccines. Can Immunol Immunother 1998;46:82-7.
12. Svensson M, Stockinger B, Wick MJ. Bone marrow-derived dendritic cells can process bacteria for MHC-I and MHC-II presentation to T cells. J Immunol 1997;158:4229-36.
13. + T cell help. J Exp Med 1997;186:65-70.
14. Nair SK, Snyder D, Rouse BT, Gilboa E. Regression of tumors in mice vaccinated with professional antigen-presenting cells pulsed with tumor extract. Int J Cancer 1997;70:706-15.
15. Larsson M, Fonteneau JF, Bhardwaj N. Dendritic cells resurrect antigens from dead cells. Trends Immunol 2001;3:141-8.
16. Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, et al. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 2001;7:297-303
17. Gong J, Avigan D, Chen D, Wu G, Koido H, Kashiwaba S, et al. Activation of antitumor cytotoxic T lymphocytes by fusions of human dendritic cells and breast carcinoma cells. Proc Natl Acad Sci USA 2000;97:2715-8.
18. Ibrahim MAA, Chain BM, Katz DR. The injured cell: the role of the dendritic cell system as a sentinel receptor pathway, Immunol Today 1995;4:181-5.
19. Schnurr M, Scholz C, Rothenfusser S, Galambos P, Dauer M, Robe J, et al. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells. Cancer Res 2002;62:2347-52.
20. Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, et al. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res 2002;62:1884-9.
21. Hoffmann TK, Meidenbauer N, Dworacki G, Kanaya H, Whiteside TL. Generation of tumor-specific T-lymphocytes by cross-priming with human dendritic cells ingesting apoptotic tumor cells. Can Res 2000;60:3542-9.
22. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997;9:10-6.
23. Anichini A, Ress S, Strassmann G, Bach FH. Inhibition of anti-class cytotoxicity by anti-class II monoclonal antibodies (MoAb). II. Blocking of anti-class I CTL clones by anti-DR MoAb. Human Immunol 1985;13:139-43.
24. Yamaki K, Hong J, Hiraizumi K, Ahn JW, Zee O, Ohuchi K. Participation of various kinases in staurosporine induced apoptosis of RAW 264.7 cells. J Pharm Pharmacol 2002;54:1535-44.
25. Thiele L, Rothen-Rutishauser B, Jilek S, Wunderli-Allenspach H, Merkle HP, Walter E. Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages? J Control Rel 2001;76:59-71.
26. Ferlazzo G, Semino C, Spaggiari GM, Meta M, Mingari MC, Melioli G. Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates. Int Immunol 2000;12:1741-7.
27. Mashishi T, Gray CM. The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes. Clin Chem Lab Med 2002;40:903-10.
28. Melero I, Vile RG, Colombo MP. Feeding dendritic cells with tumor antigens: self-service buffet or ȧ la carte? Gene Ther 2000;7:1167-70.
29. Esche C, Shurin MR, Lotze MT. The use of dendritic cells for cancer vaccination. Curr Opin Mol Ther 1999;1:72-81.
30. Fields RC, Shimizu K, Mule JJ. Murine dendritic cells pulsed with whole tumor lysates mediate potent antitumor immune responses in vitro and in vivo. Proc Natl Acad Sci USA 1998;95:9482-7.
31. Albert ML, Sauter B, Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature 1998;395:86-9.
32. Berard F, Blanco P, Davoust J, Neidhart-Berard EM, NouriShirazi M, Taquet N, et al. Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med 2000;192:1535-44.
33. Shaif-Muthana M, McIntyre C, Sisley K, Rennie I, Murray A. Dead or alive: immunogenicity of human melanoma cells when presented by dendritic cells. Cancer Res 2000;60:6441-7.
34. Henry F, Bretaudeau L, Hequet A, Haerle M, Pohl H, Rothenfusser G, et al. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. Pathobiology 1999;67:306-10.
35. Inaba K, Turley S, Yamaide F, Iyoda T, Mahnke K, Inaba M, et al. Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med 2000;188:2163-73.
36. Feng H, Zeng Y, Graner MW, Katsanis E. Stressed apoptotic tumor cells express heat shock proteins and elicit tumor-specific immunity. Blood 2001;97:3505-12.
37. Plumas J, Jacob MC, Chaperon L, Molens JP, Sotto JJ, Bensa JC. Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis. Blood 1998;8:2875-85.